Transient beneficial effects of exendin-4 treatment on the function of microencapsulated mouse pancreatic islets

Cell Transplantation

Volumn 16, Issue 1, 2007, Pages 15-22

  Bohman, Sara ^a   Waern, Ida ^a   Andersson, Arne ^a   King, Aileen ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alginate; Diabetes; Exendin 4; GLP 1; Islet transplantation; Microencapsulation

Indexed keywords

EXENDIN 4; SODIUM CHLORIDE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE OXIDATION; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; INSULIN RELEASE; ISOGRAFT; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; PANCREAS FUNCTION; PANCREAS ISLET TRANSPLANTATION; PERITONEAL CAVITY; PRIORITY JOURNAL; TISSUE CULTURE; TREATMENT OUTCOME;

MUS; RODENTIA;

EID: 34047174843     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000007783464452     Document Type: Article

References (32)

1. Bohman, S.; Andersson, A.; King, A. No differences in efficacy between non-cultured and cultured islets in reducing hyperglycemia in a non-vascularized islet graft model. Diabetes Technol. Ther. 8(5):536-545; 2006.
2. Buteau, J.; Roduit, R.; Susini, S.; Prentki, M. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells. Diabetologia 42: 856-864; 1999.
3. Buteau, J.; Spatz, M. L.; Accili, D. Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass. Diabetes 55:1190-1196; 2006.
4. Choi, S. E.; Choi, K. M.; Yoon, I. H.; Shin, J. Y.; Kim, J. S.; Park, W. Y.; Han, D. J.; Kim, S. C.; Ahn, C.; Kim, J. Y.; Hwang, E. S.; Cha, C. Y.; Szot, G. L.; Yoon, K. H.; Park, C. G. IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo. Transpl. Immunol. 13:43-53; 2004.
5. Davalli, A. M.; Scaglia, L.; Zangen, D. H.; Hollister, J.; Bonner-Weir, S.; Weir, G. C. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45:1161-1167; 1996.
6. De Vos, P.; Van Straaten, J. F.; Nieuwenhuizen, A. G.; de Groot, M.; Ploeg, R. J.; De Haan, B. J.; Van Schilfgaarde, R. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth? Diabetes 48:1381-1388; 1999.
7. Drucker, D. J. Glucagon-like peptide-1 and the islet beta-cell: Augmentation of cell proliferation and inhibition of apoptosis. Endocrinology 144:5145-5148; 2003.
8. Drucker, D. J.; Philippe, J.; Mojsov, S.; Chick, W. L.; Habener, J. F. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc. Natl. Acad. Sci. USA 84:3434-3438; 1987.
9. Duvivier-Kali, V. F.; Omer, A.; Parent, R. J.; O'Neil, J. J.; Weir, G. C. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50:1698-1705; 2001.
10. Farilla, L.; Hui, H.; Bertolotto, C.; Kang, E.; Bulotta, A.; Di Mario, U.; Perfetti, R. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143:4397-4408; 2002.
11. Fehmann, H. C.; Habener, J. F. Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells. Endocrinology 130:159-166; 1992.
12. Froud, T.; Ricordi, C.; Baidal, D. A.; Hafiz, M. M.; Ponte, G.; Cure, P.; Pileggi, A.; Poggioli, R.; Ichii, H.; Khan, A.; Ferreira, J. V.; Pugliese, A.; Esquenazi, V. V.; Kenyon, N. S.; Alejandro, R. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am. J. Transplant. 5:2037-2046; 2005.
13. Goke, R.; Fehmann, H. C.; Linn, T.; Schmidt, H.; Krause, M.; Eng, J.; Goke, B. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J. Biol. Chem. 268:19650-19655; 1993.
14. Kang, J. H.; Kim, M. J.; Jang, H. I.; Koh, K. H.; Yum, K. S.; Rhie, D. J.; Yoon, S. H.; Hahn, S. J.; Kim, M. S.; Jo, Y. H. Proximal cyclic AMP response element is essential for exendin-4 induction of rat EGR-1 gene. Am. J. Physiol Endocrinol. Metab.; 2006.
15. Kim, S.; Bae, Y. H. Long-term insulinotropic activity of glucagon-like peptide-1/polymer conjugate on islet microcapsules. Tissue Eng. 10:1607-1616; 2004.
16. King, A.; Lau, J.; Nordin, A.; Sandler, S.; Andersson, A. The effect of capsule composition in the reversal of hyperglycemia in diabetic mice transplanted with microencapsulated allogeneic islets. Diabetes Technol. Ther. 5:653-663; 2003.
17. King, A.; Lock, J.; Xu, G.; Bonner-Weir, S.; Weir, G. C. Islet transplantation outcomes in mice are better with fresh islets and exendin-4 treatment. Diabetologia 48:2074-2079; 2005.
18. King, A.; Sandler, S.; Andersson, A.; Hellerstrom, C.; Kulseng, B.; Skjak-Braek, G. Glucose metabolism in vitro of cultured and transplanted mouse pancreatic islets microencapsulated by means of a high-voltage electrostatic field. Diabetes Care 22(Suppl. 2):B121-B126; 1999.
19. Korsgren, O.; Andersson, A.; Sandler, S. Pretreatment of fetal porcine pancreas in culture with nicotinamide accelerates reversal of diabetes after transplantation to nude mice. Surgery 113:205-214; 1993.
20. Li, Y.; Hansotia, T.; Yusta, B.; Ris, F.; Halban, P. A.; Drucker, D. J. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J. Biol. Chem. 278:471-478; 2003.
21. Miao, G.; Mace, J.; Kirby, M.; Hopper, A.; Peverini, R.; Chinnock, R.; Shapiro, J.; Hathout, E. In vitro and in vivo improvement of islet survival following treatment with nerve growth factor. Transplantation 81:519-524; 2006.
22. Montana, E.; Bonner-Weir, S.; Weir, G. C. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice. J. Clin. Invest. 91:780-787; 1993.
23. Olsson, R.; Carlsson, P. O. Better vascular engraftment and function in pancreatic islets transplanted without prior culture. Diabetologia 48:469-476; 2005.
24. Park, S.; Dong, X.; Fisher, T. L.; Dunn, S.; Omer, A. K.; Weir, G.; White, M. F. Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. J. Biol. Chem. 281:1159-1168; 2006.
25. Parkes, D. G.; Pittner, R.; Jodka, C.; Smith, P.; Young, A. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism 50:583-589; 2001.
26. Ryan, E. A.; Bigam, D.; Shapiro, A. M. Current indications for pancreas or islet transplant. Diabetes Obes. Metab. 8:1-7; 2006.
27. Sandler, S.; Hellerstrom, C.; Eizirk, D. L. Effects of nicotinamide supplementation on human pancreatic islet function in tissue culture. J. Clin. Endocrinol. Metab. 77: 1574-1576; 1993.
28. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238; 2000.
29. Sharma, A.; Sorenby, A.; Wernerson, A.; Efendic, S.; Kumagai-Braesch, M.; Tibell, A. Exendin-4 treatment improves metabolic control after rat islet transplantation to athymic mice with streptozotocin-induced diabetes. Diabetologia 49:1247-1253; 2006.
30. Skoglund, G.; Hussain, M. A.; Holz, G. G. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element. Diabetes 49:1156-1164; 2000.
31. Wang, Y.; Egan, J. M.; Raygada, M.; Nadiv, O.; Roth, J.; Montrose-Rafizadeh, C. Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells. Endocrinology 136:4910-4917; 1995.
32. Xu, G.; Stoffers, D. A.; Habener, J. F.; Bonner-Weir, S. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48: 2270-2276; 1999.